BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10171404)

  • 1. National Health Laboratories settlement raises unresolved legal issues.
    Mazer RE
    Clin Lab Manage Rev; 1993; 7(2):157-60. PubMed ID: 10171404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The False Claims Act: potential liability for health care providers for fraud and abuse and beyond.
    West JC
    J Health Hosp Law; 1995; 28(1):15-20, 28. PubMed ID: 10140177
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory services regulations impact national coverage decisions, HIM.
    Willard D
    J AHIMA; 2002 Oct; 73(9):18-20, 22, 24. PubMed ID: 12371335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are you in violation?
    Lively L; Hugh J; Gomez B; Desai A
    Adm Radiol J; 1996 Jun; 15(6):44. PubMed ID: 10159375
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent healthcare fraud legislation: new prosecutional tools or congressional pie in the sky?
    Hauberg RE; Frye WD
    J Health Hosp Law; 1998; 31(1):23-33. PubMed ID: 10179118
    [No Abstract]   [Full Text] [Related]  

  • 6. Summaries of the OIG's 1997 advisory opinions.
    Traugott CA
    Benders Health Care Law Mon; 1998 May; ():10-8. PubMed ID: 10181974
    [No Abstract]   [Full Text] [Related]  

  • 7. Health care programs: fraud and abuse; revised OIG exclusion authorities resulting from Public Law 104-191--OIG. Final rule.
    Fed Regist; 1998 Sep; 63(170):46676-92. PubMed ID: 10182704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Civil False Claims Act: an important weapon in the war on health care fraud.
    Boese JT; Stanulevich BA
    Healthspan; 1992 Feb; 9(2):13-7. PubMed ID: 10117858
    [No Abstract]   [Full Text] [Related]  

  • 9. Health care programs: fraud and abuse; revised OIG sanction authorities resulting from Public Law 105-33--OIG. Notice of proposed rulemaking.
    Fed Regist; 1998 Sep; 63(170):46736-44. PubMed ID: 10182706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OIG to target therapy payments, "excessive" physician visits to SNFs in 1998.
    Natl Rep Subacute Care; 1997 Oct; 5(22):1, 3. PubMed ID: 10175531
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical laboratory billing: superfluous requirements without justification?
    Stadler S
    Clin Leadersh Manag Rev; 2004; 18(1):6-10. PubMed ID: 14968748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Federal government attacks Medicare and Medicaid fraud.
    Brown JP
    Healthspan; 1989 Apr; 6(4):11-5. PubMed ID: 10303450
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care programs: fraud and abuse; revised OIG exclusion authorities resulting from Public Law 104-191; correction--Office of Inspector General (OIG). HHS. Final rule; correcting amendment.
    Fed Regist; 1998 Oct; 63(209):57918-9. PubMed ID: 10185845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare and Medicaid false claims: prohibitions and sanctions.
    Jost TS
    Ann Health Law; 1994; 3():41-54. PubMed ID: 10139982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care programs: fraud and abuse; revised OIG civil money penalties resulting from the Health Insurance Portability and Accountability Act of 1996--Office of Inspector General (OIG), HHS. Notice of proposed rulemaking.
    Fed Regist; 1998 Mar; 63(57):14393-402. PubMed ID: 10177752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HHS releases guidelines for providers' participation in fraud amnesty program.
    Burda D
    Mod Healthc; 1995 Jun; 25(25):48. PubMed ID: 10143093
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare fraud and abuse and qui tam: the dynamic duo or the odd couple?
    Kikkawa K
    Health Matrix Clevel; 1998; 8(1):83-123. PubMed ID: 10179284
    [No Abstract]   [Full Text] [Related]  

  • 18. Warning: improper Medicare billing may be hazardous to your fiscal health.
    Werfel DM
    JEMS; 1993 Mar; 18(3):161-4. PubMed ID: 10124690
    [No Abstract]   [Full Text] [Related]  

  • 19. Basic primer on federal fraud and abuse statutes.
    Lynn N
    Benders Health Care Law Mon; 1998 May; ():4-9. PubMed ID: 10181985
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal basis and interpretations of medical necessity.
    Kazon PM
    Clin Lab Manage Rev; 1998; 12(5):375-82; discussion 382-3. PubMed ID: 10185017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.